Results 291 to 300 of about 364,334 (308)

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Lancet, The, 2003
Karl Swedberg, Christopher B Granger, Salim Yusuf   +2 more
exaly  

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Lancet, The, 2008
Kim Fox, Philippe Gabriel Steg, Michal Tendera   +2 more
exaly  

Left ventricular non-compaction cardiomyopathy

Lancet, The, 2015
Jeffrey A Towbin, Angela Lorts
exaly  

Left Ventricular Dysfunction

2007
openaire   +1 more source

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

Lancet, The, 2008
Kim Fox, Philippe Gabriel Steg, Michal Tendera   +2 more
exaly  

Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice

Signal Transduction and Targeted Therapy, 2022
exaly  

Young adult with left ventricular dysfunction

Heart
Sudipta Mondal, Richard R Raj, Sravan Kumar Gaddamedi   +2 more
openaire   +2 more sources

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

Lancet, The, 2006
Gilles R Dagenais, Janice Pogue, Salim Yusuf   +2 more
exaly  

Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study

Lancet, The, 2016
Josep Rodés-Cabau
exaly  

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

Lancet, The, 2001
Fd Richard Hobbs
exaly